Загрузка...
Concomitant imatinib and ibrutinib in a patient with chronic myelogenous leukemia and chronic lymphocytic leukemia
The availability of kinase and other small‐molecule inhibitors to treat hematologic malignancies is increasing. Accordingly, novel regimens that employ these therapeutics are rapidly evolving. Herein we report the safe and effective administration of two targeted kinase inhibitors in a patient with...
Сохранить в:
| Опубликовано в: : | Clin Case Rep |
|---|---|
| Главные авторы: | , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
John Wiley and Sons Inc.
2017
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5458012/ https://ncbi.nlm.nih.gov/pubmed/28588835 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ccr3.974 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|